Dog /

Breed profile · FDA CVM July 2026 extract

Basenji adverse-event record

Adverse-event filings for Basenji (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#147 of 510
by report volume (all breeds)
466
FDA CVM reports on file
5.4%
death-coded share of reports
#113 of 275
by death-coded share (≥50 reports)

How the 466 reports break down

By recorded gender -- every report on file for Basenji, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 48 36 24 12 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Basenji drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Basenji ranks #147 of 510 by total reports (466) and #113 of 275 by death-coded share (5.4%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#147
This breed, reports of 510
#113
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Basenji has 466 reports now versus 457 in that prior snapshot: 9 more (2.0%).

Report change
+9
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Basenji changes

Total Reports

466

Above-median volume

Deaths Reported

25

of 466 reports

Death-coded share of reports

5.4%

Above-median death-coded share

Avg Age at Report

6.0 yr

14.9 kg avg weight

Breed Safety Scorecard

C (58/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate D
5.4%

Share of reports coded as a fatality

Euthanasia rate D
2.4%

Share of reports resulting in euthanasia

Full recovery rate A
37.8%

Share of reports coded "Recovered/Normal"

5-year trend C+
-5%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Basenji death-coded reports 5.4%
Cross-breed median

5.4% of 466 basenji reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Basenji's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

5% 59th percentile Higher share than 59% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Basenji 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 14.9 kg (32.9 lbs)

Top Reported Reactions

Vomiting 110
Lethargy (see also Central nervous system depression in 'Neurological') 42
Emesis 41
Diarrhoea 33
INEFFECTIVE, HEARTWORM LARVAE 28
Lack of efficacy (endoparasite) - heartworm 28
Seizure NOS 23
Lack of efficacy - NOS 22

Most Referenced Drugs

Milbemycin Oxime + Spinosad 86
Ivermectin + Pyrantel As Pamoate Salt 58
Afoxolaner 40
Spinosad 33
Pyrantel Pamoate;Sarolaner 27
Moxidectin 23
Fluralaner Chew Tablets 21
Milbemycin Oxime + Praziquantel 16

Outcome Breakdown

Recovered/Normal
176 (38.9%)
Outcome Unknown
129 (28.5%)
Ongoing
103 (22.8%)
Recovered with Sequela
19 (4.2%)
Died
14 (3.1%)
Euthanized
11 (2.4%)

Gender Distribution

Female 263 (56.4%)
Male 194 (41.6%)
Unknown 6 (1.3%)
Mixed 3 (0.6%)

Reports by Year

Year Reports Trend
2010 13
2011 13
2012 29
2013 23
2014 34
2015 35
2016 41
2017 42
2018 44
2019 48
2020 25
2021 20
2022 22
2023 19
2024 30
2025 19
2026 9

Basenji: high-volume FDA adverse-event cohort

Signature read: 466 reports place Basenji in the upper third of breed filing volume (#147 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Basenji sits at #147 of 510 by report volume among all breeds and #121 of 298 among dog breeds, with 466 reports and 25 (5.4%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #113 of 275. Mean age at report: 6.0 years, average weight 14.9 kg (32.9 lbs).

Top reported signs: Vomiting (110), Lethargy (see also Central nervous system depression in 'Neurological') (42), Emesis (41). Most-referenced drug: Milbemycin Oxime + Spinosad (86 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (58) and Afoxolaner (40).

Outcome coding on 452 status-recorded reports is dominated by Recovered/Normal (38.9%). Annual submissions ranged 9-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Shepherd Dog - Anatolian
471 reports · 4.9% death-coded
Terrier - Tibetan
451 reports · 2.7% death-coded
Coonhound - Treeing Walker
489 reports · 3.5% death-coded
Chinese Crested Dog (unspecified)
490 reports · 3.7% death-coded
Pointing Dog - German Wire-haired
490 reports · 3.9% death-coded
Terrier - Fox Wire
434 reports · 5.1% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Basenji drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (5.4% death-coded here).

Egyptian Mau 5.3% · Cat Norwegian Forest 5.7% · Cat Scottish Fold Longhair 4.8% · Cat Bengal 4.6% · Cat

Similar average weight

Nearest other-species breeds by reported average weight (14.9 kg here).

Wild cat 14.5 kg · Cat Monkey (unspecified) 11.6 kg · Monkey Primate (other) 10.1 kg · Primate Pygmy 20.3 kg · Goat

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Basenji? ▼
There are 466 adverse event reports involving Basenji in the FDA database, of which 25 were death-coded (5.4% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Basenji ranks #147 of 510 by report volume among all breeds PlainBreed indexes (#121 of 298 among dog breeds).
Where does Basenji sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Basenji is #147 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #121 of 298. Among breeds with at least 50 reports, its death-coded share ranks #113 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Basenji? ▼
The most commonly reported adverse reactions for Basenji are Vomiting (110 reports), Lethargy (see also Central nervous system depression in 'Neurological') (42 reports), Emesis (41 reports), Diarrhoea (33 reports), INEFFECTIVE, HEARTWORM LARVAE (28 reports).
What drugs are most frequently associated with Basenji adverse events? ▼
The drugs most frequently referenced in Basenji adverse event reports are Milbemycin Oxime + Spinosad (86 reports), Ivermectin + Pyrantel As Pamoate Salt (58 reports), Afoxolaner (40 reports), Spinosad (33 reports), Pyrantel Pamoate;Sarolaner (27 reports).
What is the average age of Basenji in adverse event reports? ▼
The average age of Basenji at the time of adverse event reports is 6.0 years, with an average weight of 14.9 kg (32.9 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Basenji (Dog), extract as of July 2026 extract. 466 reports · 25 death-coded (5.4% of reports, not a mortality rate) · #147 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →